Supportive Care and Complication Prevention in Sepsis and Septic Shock
Objective
Recommend appropriate supportive care and monitoring to mitigate the morbidity of sepsis and septic shock.
1. Mechanical Ventilation Strategies
Sepsis-induced Acute Respiratory Distress Syndrome (ARDS) demands timely recognition of respiratory failure and application of lung-protective ventilation to reduce ventilator-associated lung injury.
Indications for Invasive Ventilation
- Refractory Hypoxemia: PaO₂/FiO₂ ratio ≤150 mmHg despite noninvasive support.
- Respiratory Muscle Fatigue: Respiratory rate >35 breaths/min, use of accessory muscles, or paradoxical breathing.
- Hypercapnic Acidemia: Arterial pH <7.25 due to inadequate ventilation.
- Airway Protection: Inability to clear secretions or protect the airway due to altered mental status.
Lung-Protective Ventilation Targets
- Tidal Volume (Vₜ): Target 6 mL/kg of predicted body weight (PBW).
- Plateau Pressure (Pₚₗₐₜ): Maintain ≤30 cm H₂O to minimize barotrauma.
- Driving Pressure (ΔP): Keep below 15 cm H₂O (ΔP = Pₚₗₐₜ – PEEP), as this correlates strongly with mortality.
- PEEP Titration: Use higher PEEP/FiO₂ tables to improve oxygenation while preventing alveolar collapse.
Adjunctive ARDS Therapies
- Prone Positioning: For patients with a PaO₂/FiO₂ <150 mmHg, prone for at least 12-16 hours per day.
- Neuromuscular Blockade: A continuous infusion (e.g., cisatracurium) for up to 48 hours may be considered for severe patient-ventilator dyssynchrony.
- Venovenous ECMO: Reserved for refractory hypoxemia or uncompensated hypercapnia at experienced centers.
Clinical Pearl: Early Controlled Intubation
Delaying intubation can lead to patient self-inflicted lung injury (P-SILI) from high respiratory drive and large tidal volumes. Proactive, controlled intubation prevents this and avoids hemodynamic collapse that can occur during an emergent procedure.
Clinical Pearl: Timing of Prone Positioning
The survival benefit of prone positioning is greatest when initiated early, ideally within 36 hours of the onset of moderate-to-severe ARDS. It improves ventilation-perfusion matching and reduces lung stress.
2. Hemodynamic and Organ Support Monitoring
In septic shock, invasive monitoring and dynamic indices are crucial for guiding fluid management and detecting organ dysfunction, moving beyond reliance on static pressure measurements.
Arterial Pressure Monitoring
A radial arterial line is standard for continuous blood pressure monitoring and allows for frequent arterial blood gas sampling. The waveform itself provides clues: a steep upstroke with a low dicrotic notch may suggest vasodilation, while a narrow pulse amplitude points to low stroke volume.
Dynamic Fluid-Responsiveness Indices
These methods predict which patients will increase their stroke volume in response to a fluid bolus, helping to avoid harmful fluid overload.
- Pulse Pressure Variation (PPV) & Stroke Volume Variation (SVV): In mechanically ventilated patients with no spontaneous breaths, a PPV >12% or SVV >10% suggests fluid responsiveness. These are unreliable in arrhythmias or with low tidal volumes.
- Passive Leg Raise (PLR) Test: A temporary, reversible “autobolus” of ~300 mL of blood. An increase in stroke volume (measured by cardiac output monitor or echocardiography) of ≥10% strongly predicts fluid responsiveness.
Renal Monitoring and Renal Replacement Therapy (RRT)
- Triggers for Concern: Oliguria (<0.5 mL/kg/h for >6 hours) or a rapid rise in serum creatinine are early signs of acute kidney injury (AKI).
- Indications for RRT: Typically initiated for KDIGO stage 2–3 AKI with complications, such as severe metabolic acidosis, hyperkalemia, or significant volume overload refractory to diuretics.
- Modality Choice: Continuous RRT (e.g., CVVH) is generally preferred over intermittent hemodialysis in hemodynamically unstable patients to ensure gentle fluid removal and better metabolic control.
Clinical Pearl: The Power of the PLR
The passive leg raise test is one of the most reliable dynamic indices because it is risk-free and can be repeated as needed. It provides a direct assessment of preload reserve without administering exogenous fluid.
3. Prevention of ICU-Related Complications
Prophylactic measures for venous thromboembolism (VTE), stress ulcers, and device-related infections are cornerstone interventions to limit ICU-acquired morbidity and improve outcomes.
| Prophylaxis Type | Primary Indication | First-Line Agent | Notes |
|---|---|---|---|
| VTE Prophylaxis | Immobility + Sepsis-induced hypercoagulability | Enoxaparin 40 mg SC daily | Reduce to 30 mg for CrCl <30 mL/min. Use UFH if high bleed risk. Use mechanical compression if contraindicated. |
| Stress Ulcer Prophylaxis | Mechanical ventilation >48h OR coagulopathy | Pantoprazole 40 mg IV daily | Reassess need daily. Discontinue when risk factors resolve to reduce risk of C. difficile and pneumonia. |
Nosocomial Infection Prevention Bundles
- Ventilator-Associated Pneumonia (VAP) Bundle:
- Head-of-bed elevation to 30–45°
- Daily sedation interruptions and spontaneous breathing trials
- Oral care with chlorhexidine
- Use of endotracheal tubes with subglottic secretion drainage
- Central Line-Associated Bloodstream Infection (CLABSI) Bundle:
- Strict hand hygiene and maximal barrier precautions during insertion
- Skin antisepsis with chlorhexidine
- Daily review of central line necessity with prompt removal when no longer needed
Clinical Pearl: The Impact of Bundles
Consistent adherence to care bundles has a profound impact on patient safety. Studies show that VAP and CLABSI bundles can reduce infection rates by approximately 40% and 60%, respectively. Daily evaluation prevents the unnecessary continuation of these measures once risk factors resolve.
4. Management of Iatrogenic Sequelae
Vigilant monitoring for drug-related organ dysfunction and ICU-acquired syndromes is essential to preserve long-term recovery potential.
A. Drug-Induced Organ Dysfunction
| Drug Class | Key Monitoring Parameter | Mitigation Strategy |
|---|---|---|
| Aminoglycosides | Trough level (<1 mg/L), Serum Creatinine | Use extended-interval dosing (e.g., gentamicin 7 mg/kg). |
| Vancomycin | AUC/MIC (target 400-600), Serum Creatinine | Use AUC-guided dosing; consider continuous infusion for stable levels. |
| Amphotericin B | Creatinine, Potassium, Magnesium | Use liposomal formulations to reduce nephrotoxicity. |
| Propofol | Triglycerides, Creatine Kinase (CK) | Monitor for Propofol Infusion Syndrome; limit dose and duration. |
B. Delirium and ICU-Acquired Weakness
The ABCDEF bundle is a evidence-based, multicomponent strategy to reduce delirium, improve pain management, and decrease long-term cognitive impairment.
5. Multidisciplinary Goals-of-Care and Palliative Integration
Early, structured discussions are critical to align high-intensity interventions with patient values, prevent nonbeneficial treatments, and support families.
Timing and Structure of Discussions
- Initiate goals-of-care discussions within 72 hours of ICU admission.
- Use clear, empathetic language to explain prognosis, likely outcomes (including functional status), and the burdens of continued treatment.
- Document discussions and any advance directives (e.g., POLST, living will) clearly in the medical record.
Triggers for Palliative Care Consultation
- Refractory shock or respiratory failure despite maximal medical therapy.
- Progressive multi-organ failure with rising lactate (>4 mmol/L).
- Underlying comorbidities that confer a limited life expectancy (<6 months).
Clinical Pearl: Benefits of Early Family Conferences
Proactive family meetings led by the multidisciplinary team not only improve family satisfaction and reduce psychological distress but have also been shown to reduce the length of stay in the ICU for patients who ultimately transition to comfort-focused care, ensuring that care aligns with patient and family goals.
References
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49:e1063–e1143.
- Brower RG, Matthay MA, Morris A, et al; ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for ARDS. N Engl J Med. 2000;342:1301–1308.
- Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on survival in acute respiratory failure. N Engl J Med. 2001;344:481–488.
- Frat JP, Thille AW, Mercat A, et al; FLORALI Study Group. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–2196.
- Russell JA, Walley KR, Singer J, et al; VASST Investigators. Vasopressin versus norepinephrine in septic shock. N Engl J Med. 2008;358:877–887.
- The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683–1693.
- Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809–818.
- Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med. 2002;28:29–37.
